These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31107614)

  • 1. Letter by Hilfiker-Kleiner et al Regarding Article, "Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes".
    Hilfiker-Kleiner D; Sliwa K; Bauersachs J
    Circulation; 2019 May; 139(21):e990-e991. PubMed ID: 31107614
    [No Abstract]   [Full Text] [Related]  

  • 2. Response by Naftali-Shani et al to Letter Regarding Article, "Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes".
    Naftali-Shani N; Arad M; Kuperstein R; Amit U; Leor J
    Circulation; 2019 May; 139(21):e992-e993. PubMed ID: 31107621
    [No Abstract]   [Full Text] [Related]  

  • 3. Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes.
    Naftali-Shani N; Molotski N; Nevo-Caspi Y; Arad M; Kuperstein R; Amit U; Huber I; Zeltzer LA; Levich A; Abbas H; Monserrat L; Paret G; Leor J
    Circulation; 2018 Dec; 138(23):2721-2723. PubMed ID: 30571272
    [No Abstract]   [Full Text] [Related]  

  • 4. Human iPSC-Derived Cardiomyocytes of Peripartum Patients With Cardiomyopathy Reveal Aberrant Regulation of Lipid Metabolism.
    Hoes MF; Bomer N; Ricke-Hoch M; de Jong TV; Arevalo Gomez KF; Pietzsch S; Hilfiker-Kleiner D; van der Meer P
    Circulation; 2020 Dec; 142(23):2288-2291. PubMed ID: 33284656
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter by Dalzell et al Regarding Article, "Peripartum Cardiomyopathy".
    Dalzell JR; Barton AK; McKeag NA
    Circulation; 2016 Aug; 134(7):e81-2. PubMed ID: 27528650
    [No Abstract]   [Full Text] [Related]  

  • 6. Response by Arany and Elkayam to Letter Regarding Article, "Peripartum Cardiomyopathy".
    Arany Z; Elkayam U
    Circulation; 2016 Aug; 134(7):e83-4. PubMed ID: 27528651
    [No Abstract]   [Full Text] [Related]  

  • 7. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
    Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
    Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
    J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Cardiomyopathy and Arrhythmias in Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Chen SN; Taylor MRG; Mestroni L
    Circ Genom Precis Med; 2018 Mar; 11(3):e002088. PubMed ID: 29545481
    [No Abstract]   [Full Text] [Related]  

  • 10. 12‑lead ECG as an emerging risk stratifier in peripartum cardiomyopathy.
    Tak BT; Cetin EHO; Ulvan N; Cay S; Aras D
    Int J Cardiol; 2019 Oct; 293():185. PubMed ID: 31447034
    [No Abstract]   [Full Text] [Related]  

  • 11. What Should Be Generalized Diagnostic Markers for Peripartum Cardiomyopathy?
    Sakuma I; Anzai T
    Circ J; 2017 Oct; 81(11):1578-1579. PubMed ID: 29021419
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular events underlying pregnancy-induced cardiomyopathy.
    Leinwand LA
    Cell; 2007 Feb; 128(3):437-8. PubMed ID: 17289564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CURRENT MANAGEMENT OF PERIPARTUM CARDIOMYOPATHY: A REVIEW.
    Dodiyi-Manuel ST; Ezennaka RC
    Niger J Med; 2015; 24(4):363-9. PubMed ID: 27487615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripartum Cardiomyopathy.
    Gleicher N
    N Engl J Med; 2024 Apr; 390(15):1443. PubMed ID: 38631014
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to '12‑lead ECG as an emerging risk stratifier in peripartum cardiomyopathy'.
    Hoevelmann J; Viljoen CA; Millar RS; Manning K; Ntsekhe M; Sliwa K
    Int J Cardiol; 2019 Dec; 297():91. PubMed ID: 31431295
    [No Abstract]   [Full Text] [Related]  

  • 16. Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.
    Buikema JW; Wu SM
    Curr Cardiol Rep; 2017 Apr; 19(4):30. PubMed ID: 28315121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Readmissions Among Patients With Peripartum Cardiomyopathy.
    Çelik O; Çil C; Biteker FS; Biteker M
    Am J Cardiol; 2018 Sep; 122(5):911. PubMed ID: 30049461
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripartum Cardiomyopathy: Is It All in the Timing?
    Roth Flach RJ; Khankin EV
    Hypertension; 2020 Jan; 75(1):33-34. PubMed ID: 31707839
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripartum Cardiomyopathy. Reply.
    Arany Z
    N Engl J Med; 2024 Apr; 390(15):1443. PubMed ID: 38631015
    [No Abstract]   [Full Text] [Related]  

  • 20. The Search for a Crystal Ball to Predict Early Recovery From Peripartum Cardiomyopathy?
    Elkayam U; Habakuk O
    JACC Heart Fail; 2016 May; 4(5):389-91. PubMed ID: 27126284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.